Franklin Resources Inc Alx Oncology Holdings Inc Transaction History

Franklin Resources Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$10.95 - $16.79 $110,014 - $168,689	10,047 New	10,047 $112,000
Q4 2021 Feb 11, 2022	SELL	$21.49 - $74.4 $4.93 Million - $17.1 Million	-229,505 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$52.2 - $75.23 $1.54 Million - $2.22 Million	29,500 Added 14.75%	229,505 $12.5 Million
Q4 2020 Feb 10, 2021	BUY	$34.11 - $112.26 $170 - $561	5 Added 0.0%	200,005 $17.2 Million
Q3 2020 Nov 12, 2020	BUY	$29.36 - $47.1 $5.87 Million - $9.42 Million	200,000 New	200,000 $7.55 Million

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.